It helps the body produce insulin, lowers appetite, and can aid in weight loss for some people
In June 2025, the European Medicines Agency (EMA) officially confirmed that NAION is a very rare side effect of semaglutide drugs, recommending urgent updates to product labeling and treatment protocols
How Regular Check Ins Reduce Risk and Improve Outcomes Frequent follow-up visits let providers track symptoms, weight loss speed, and any lab or imaging findings
The injectable medication is approved for once-a-week treatment of Type 2 diabetes in adults and is sold under the brand name "Obeda" in India
However, the summary near the top of the page describes a broader company standard of at least 98.5%
Number of Sessions More sessions mean higher overall cost